Key Fed Inflation Gauge Drops to 2.2% in August, Easing Path for Rate Cuts
Inflation in the U.S. moved closer to the Federal Reserve’s target in August, signaling progress that could pave the way for future interest rate cuts. [more…]
Barry FitzGerald: Garimpeiro charts the rise, fall and possible rise again of Novo Resources
The art of stock promotion was carried to dizzying heights in 2017 by Canadian explorer Novo Resources (ASX:NVO). It was the lead company in what [more…]
This is the worst song to play during sex, according to science
To set the mood in the bedroom, you’ll need bangers on queue – but most people are choosing the wrong tunes, researchers say. Here’s what [more…]
ASX Small Caps Weekly Wrap: Chinese stimulus delivers a bumper week for Materials
The ASX 200 barely broke even this week, up just 0.25pc Stimulus in China sent Materials soaring, up nearly 10pc for the week Who won [more…]
Gold Digger: US rate cuts spark new gold record as De Grey shuns takeover offer
US rate cuts spark new gold highs up to US$2670/oz De Grey hits 9-month stock price high after it baulks at Agnico takeover offer And [more…]
Closing Bell: Investors rush to mining stocks after China news; while Star crashes 40pc to new low
ASX rises modestly with mining stocks leading gains Fortescue surges nearly 5pc as iron ore prices climb Star Entertainment plunges over 40pc after trading [more…]
Monsters of Rock: China bulls send iron ore, copper flying
Chinese stimulus speculation continues to send bulls racing back to resources MinRes soars, up over 30% for the week as lithium, copper and iron ore [more…]
Scott Power: Which health ‘underperformer’ just made a big move?
Healius offloads its radiology arm for $965m to focus on core pathology business Sigma H1 FY25 results in line with expectations as countdown on for [more…]
The Ethical Investor: This week’s grilling shows social media’s a game changer for ESG reputation
Last week it was Macquarie, now Australia’s supermarkets are in the news for the wrong reasons Coles and Woolworths are in hot water with the [more…]
Top 10 at 11: Medtech, cancer drugs and fintech are this morning’s big winners
Good morning, and welcome to Stockhead’s Top 10 at shortly-before-11-ish, which is meant to highlight the best (and sometimes worst) performing ASX stocks in morning [more…]